ClinicalTrials.gg
Not yet recruitingNCT07942935Updated Nov 17, 2026

Novel Dietary Interventions in Functional Dyspepsia

An interventional study of low histidine diet and low tryptophan diet in Functional Dyspepsia, sponsored by University of Michigan. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 77 studies in Dyspepsia with a site in United States — 14 open to participants now, 18 under way, 1 of them phase 3. Dyspepsia · United States.

Planned enrollment
43rd of 67
30 · median 50
Started
2026
with 3 others
No phase
34 of 77
10 open now
Primary completion
2027-11
later than 9 of 17 live
Registered
77th of 77
by date

Among the 77 studies in Dyspepsia with a site in United States, this one is the 43rd largest by planned enrollment of the 67 interventional ones that give a count, is one of 4 that started in 2026, is one of 34 with no phase, reaches primary completion later than 9 of the 17 other live ones, and was the 77th registered.

Dyspepsia

373 studies on the registry are indexed under Dyspepsia; 67 are open to participants now.

Browse Dyspepsia studies →

Open to participants now

14 of the 77 studies in Dyspepsia with a site in United States are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 46 Dyspepsia studies recruiting now, 16 (35%) set no upper age limit and 23 (50%) stop at 75 or younger; 2 take children under 18; 8 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 77 studies in Dyspepsia with a site in United States, or all of them as a file.
02

Study summary

This pilot study will test whether people with functional dyspepsia can follow two new dietary approaches and whether these diets may improve symptoms. Thirty adults will be randomly assigned to follow a low-histidine diet, a low-tryptophan diet, or a comparison diet for six weeks. The study aims to reduce-not eliminate- intake. The comparison diet provides dietary instructions that are not intended to reduce either nutrient.

The main goal is to determine whether participants intake of these nutrients can change through diet approaches.

Participants will receive nutrition counseling, follow the diet assigned, describe food consumption during dietary-recall interviews, complete questionnaires, provide blood and urine samples, and swallow a capsule that measures movement and gases in the digestive tract before and after the intervention.

03

Conditions studied

  • Functional Dyspepsia

Browse trials for

Keywords

  • Low-histidine diet
  • Low-tryptophan diet
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • meeting Rome IV criteria for Functional dyspepsia (FD)
  • planned esophagogastroduodenoscopy (EGD) as part of clinical care

Exclusion criteria

Exclusion Criteria:

  • Documented drug or alcohol use disorder
  • Documented history of an eating disorder
  • Habitual vegetarian or vegan diet
  • Currently pregnant or breastfeeding or anticipating pregnancy during study period
  • Unwilling to follow a low histidine or low tryptophan diet
  • Unexplained weight loss, dysphagia, or other warning signs that would prompt evaluation with esophagogastroduodenoscopy - if present would need to ensure no evidence of Los Angeles (LA) grade C or D esophagitis or peptic ulcer disease on EGD performed as part of clinical care
  • Use of daily opioid pain medication or glucagon-like peptide receptor 1(GLP-1) agonist
  • Current use of metoclopramide or other prokinetic medication
  • History of gastrointestinal surgery
  • Poorly controlled diabetes mellitus (HgbA1c >10%)
  • Known allergy to ingredient in Atmo Motility Bar (Rolled oats, glucose syrup, soy nuggets, rice bran crisps, brown rice syrup, pea protein powder, glycerine, natural vanilla extract and monkfruit juice extract)
  • Inability to swallow pills the size of large vitamins
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    low histidine diet

    Approximately 10 participants between the ages of 18-75 years old.

    Behavioral: low histidine diet

  • Experimental
    low tryptophan diet

    Approximately 10 participants between the ages of 18-75 years old.

    Behavioral: low tryptophan diet

  • Placebo comparator
    sham diet

    Approximately 10 participants between the ages of 18-75 years old.

    Behavioral: sham diet

Interventions

  • Behaviorallow histidine diet

    Histamine and histidine are used interchangeably in study materials. Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary strategies to reduce histidine intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6.

  • Behaviorallow tryptophan diet

    Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary strategies to reduce tryptophan intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6.

  • Behavioralsham diet

    Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary recommendations that will not lead to an impact in dietary histidine or tryptophan intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6.

06

What researchers measure

Primary outcomes

  1. Change in 24-hour dietary histidine

    Histidine is assessed through 24-hour dietary recall using Nutrition Data System for Research (NDSR)

    Time frame: baseline, 6 week

  2. Change in 24-hour dietary tryptophan

    Tryptophan is assessed through 24-hour dietary recall using NDSR

    Time frame: baseline, 6 week

Secondary outcomes

  1. Percentage of participants who meet a 30% reduction in dietary tryptophan

    Tryptophan is assessed through 24-hour dietary recall using NDSR

    Time frame: 6 week

  2. Percentage of participants who meet a 30% reduction in dietary histidine

    Histidine is assessed through 24-hour dietary recall using NDSR

    Time frame: 6 week

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.

Of 71 non-industry interventional studies with no phase under Dyspepsia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 28. This study's planned 12 months is below that.

Counting every sponsor, half of 79 studies reached it within 17 months; a quarter within 9 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 17, 2026
StartEst.
Nov 2026
Primary completionEst.
Nov 2027
CompletionEst.
Nov 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07942935
Responsible party
William Hirsch (Fellow, Division of Gastroenterology & Hepatology, University of Michigan) — Principal investigator
First posted
Nov 17, 2026
Start date
Nov 2026 (estimated)
Primary completion
Nov 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

William Hirsch, MD
Contact
whirsch@med.umich.edu
734-936-4998

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion